Skip to main content
. 2012 Aug 27;10:173. doi: 10.1186/1479-5876-10-173

Table 4.

Association ofCDKN2Amethylation and clinico-pathological features stratified by microsatellite instability (MSI) status

Feature
 
CDKN2A in MSS/MSI-L (n;%)
P-value
CDKN2A in MSI-H (n;%)
P-value
 
 
Negative
Positive
 
Negative
Positive
 
    (n = 272; 81.4%) (n = 62; 18.6%)   (n = 42; 68.9%) (n = 19; 31.2%)  
Age
Mean (range)
69.5 (40–95)
69.9 (44–88)
0.788
68.4 (45–87)
68.2 (50–89)
0.9897
Tumor size
Mean (range)
48.0 (5–130)
49.8 (4–105)
0.523
54.9 (19–160)
62.8 (15–170)
0.3737
Tumor location
Left-sided
193 (71.2)
34 (54.8)
0.0125
24 (57.1)
4 (22.2)
0.013
 
Right-sided
78 (28.8)
28 (45.2)
 
18 (42.9)
14 (77.8)
 
Gender
Female
149 (54.8)
34 (54.8)
0.9932
20 (47.6)
10 (52.6)
0.7169
 
Male
123 (45.2)
28 (45.2)
 
22 (52.4)
9 (47.4)
 
Histological subtype
Non-mucinous
253 (93.0)
54 (87.1)
0.1142
39 (92.9)
16 (84.2)
0.2863
 
Mucinous
16 (5.9)
8 (12.9)
 
3 (7.1)
2 (10.5)
 
Tumor grade
G1-2
261 (98.1)
54 (87.1)
<0.0001
37 (88.1)
14 (73.7)
0.2608
 
G3
5 (1.9)
8 (12.9)
 
5 (11.9)
5 (26.3)
 
pT classification
pT1-2
59 (22.1)
13 (21.0)
0.8354
12 (28.6)
0 (0.0)
0.0093
 
pT3-4
207 (77.8)
49 (79.0)
 
30 (71.4)
19 (100.0)
 
pN classification
pN0
140 (53.4)
23 (37.1)
0.0207
26 (66.7)
10 (52.6)
0.3012
 
pN1-2
122 (46.6)
39 (62.9)
 
13 (33.3)
9 (47.4)
 
Vascular invasion
Absent
186 (69.9)
37 (59.7)
0.1193
35 (83.3)
11 (57.9)
0.0326
 
Present
80 (30.1)
25 (40.3)
 
7 (16.7)
8 (42.1)
 
Invasive margin
Pushing
69 (26.0)
12 (19.7)
0.2996
26 (61.9)
6 (31.6)
0.0281
 
Infiltrating
196 (74.0)
49 (80.3)
 
16 (38.1)
13 (68.4)
 
Peritumoral lymphocytic inflammation
Absent
211 (79.3)
51 (82.3)
0.6037
27 (64.3)
13 (68.4)
0.7529
 
Present
55 (20.7)
11 (17.7)
 
15 (35.7)
6 (31.6)
 
KRAS (codon 12/13)
Wild-type
185 (69.0)
41 (68.3)
0.9161
26 (65.0)
14 (93.3)
0.0356
 
Mutation
83 (31.0)
19 (31.7)
 
14 (35.0)
1 (6.7)
 
BRAF (codon V600E)
Wild-type
245 (96.8)
42 (75.0)
<0.0001
30 (79.0)
8 (44.4)
0.0098
  Mutation 8 (3.2) 14 (25.0)   8 (21.0) 10 (55.6)